Original ArticleRegional Variance in Disability and Quality-of-Life Outcomes After Surgery for Grade I Degenerative Lumbar Spondylolisthesis: A Quality Outcomes Database Analysis
Introduction
Lumbar degenerative disease is a pervasive cause of disability and pain, with lumbar stenosis affecting more than 200,000 adults in the United States (US)1 and lumbar spondylolisthesis affecting 11.5% of the US population.2 Surgical interventions including decompressive laminectomy with or without instrumentation and fusion may be indicated in patients who have failed conservative medical management of symptomatic lumbar spondylolisthesis.3,4 Importantly, the Spine Patient Outcomes Research Trial demonstrated that surgery for degenerative lumbar disease improved health and decreased cost per quality-adjusted life year compared with medical management alone.5 After recent health policy reforms, increased emphasis has been placed on value-based medical care, including patient outcomes after surgery for degenerative lumbar disease.6
Regional variations in lumbar spinal surgery techniques/rates,7, 8, 9 costs,10,11 pain control regimens,12 and patient outcomes10 have been studied previously. Prior studies have also investigated quality-of-life differences between international cohorts 13,14; however, to our knowledge, no study has specifically investigated regional differences in patient disability or quality of life at long-term follow-up. As multi-institutional patient registries and multicenter studies have become more commonplace, regional differences in outcome measures reported in such studies are potentially under-reported and may affect how results from such studies are interpreted.
The Neuropoint Alliance Quality Outcomes Database (QOD) is a prospective, longitudinal, multicenter patient registry developed specifically to study patient outcomes after neurosurgical intervention.15 Since the formation of the Neuropoint alliance in 2008, the QOD has collected perioperative data as well as postoperative follow-up information at each participating site. Institutions from across the US are represented in the QOD data set, with a total of 12 participating high-volume sites with representation from each of the 4 mainland US Census Bureau geographic regions (Northeast, South, Midwest, West).
The objective of this study was to analyze regional variation in disability and quality-of-life outcomes after 1- or 2-level decompression and/or fusion for grade 1 spondylolisthesis using the multi-institutional QOD.
Section snippets
Data Source
The QOD is the first neurosurgical specialty–specific multicenter database with an initial focus on spine procedures and outcomes, and it contains de-identified patient data. Prior studies have thoroughly described the QOD data collection methodology.15, 16, 17, 18 Each participating site had institutional review board approval to enroll patients for data collection. Twelve sites from across the US were included in this retrospective review of the prospective database (the 12 highest enrolling
Results
Six hundred eight patients from 12 centers were included. Of these, 517 patients (85.0%) had ODI data and 492 patients (80.9%) had EQ-5D data at 24 months. Southern states had the largest representation (304 patients; 5 centers) followed by Northeastern (114 patients; 3 centers), Midwestern (96 patients; 2 centers), and Western (94 patients; 2 centers) states.
Table 1 displays patient baseline variables across geographic region. Age at surgery (patients in Northeast and Western regions tended to
Discussion
Patient disability and quality of life after surgical intervention for lumbar degenerative disease are crucial metrics of surgical success. To our knowledge, no prior study had reported regional variation in disability and quality-of-life outcomes after surgery for degenerative lumbar spondylolisthesis. In a cohort of 498 patients from all 4 major geographic regions of the US from a high-quality, neurosurgery-specific, prospective patient registry, we report significant regional variation in
Conclusions
Significant regional variation exists for disability outcomes, but not quality of life, at 24 months after spinal surgery for grade I degenerative spondylolisthesis. Patients from Southern states have the highest baseline disability burden but show the greatest improvement disability at postoperative follow-up. Despite regional variation in disability outcomes, overall improvement in both disability and quality of life was seen across regions and were sustained at long-term follow-up. These
CRediT authorship contribution statement
Brandon A. Sherrod: Conceptualization, Data curation, Writing - original draft, Writing - review & editing. Praveen V. Mummaneni: Conceptualization, Data curation, Writing - review & editing. Mohammed Ali Alvi: Data curation, Writing - review & editing. Andrew K. Chan: Data curation, Writing - review & editing. Mohamad Bydon: Data curation, Writing - review & editing. Steven D. Glassman: Data curation, Writing - review & editing. Kevin T. Foley: Data curation, Writing - review & editing. Eric
Acknowledgment
We would like to thank Kristin Kraus for editorial assistance.
References (30)
- et al.
Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spondylolisthesis
Spine J
(2016) - et al.
Geographic variation in lumbar fusion for degenerative disorders: 1990 to 2000
Spine J
(2007) - et al.
Regional variations in spine surgery: current challenges and potential solutions
Spine J
(2016) - et al.
Regional variation in opioid use after lumbar spine surgery
World Neurosurg
(2019) - et al.
Accurately measuring the quality and effectiveness of lumbar surgery in registry efforts: determining the most valid and responsive instruments
Spine J
(2014) - et al.
Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales
Spine J
(2008) - et al.
Management of lumbar spinal stenosis
BMJ
(2016) - et al.
Spondylolysis and spondylolisthesis: prevalence and association with low back pain in the adult community-based population
Spine (Phila Pa 1976)
(2009) - et al.
The current management of lumbar spondylolisthesis
J Neurosurg Sci
(2013) - et al.
Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial
JAMA
(2006)
Cost per quality-adjusted life year gained of revision neural decompression and instrumented fusion for same-level recurrent lumbar stenosis: defining the value of surgical intervention
J Neurosurg Spine
Trends in isolated lumbar spinal stenosis surgery among working US adults aged 40-64 years, 2010-2014
J Neurosurg Spine
US regional variations in rates, outcomes, and costs of spinal arthrodesis for lumbar spinal stenosis in working adults aged 40-65 years
J Neurosurg Spine
Trends and geographic variations in major surgery for degenerative diseases of the hip, knee, and spine
Health Aff (Millwood)
Geographic and ethnic variations in radiographic disability thresholds: analysis of North American and Japanese operative adult spinal deformity populations
Neurosurgery
Cited by (0)
Conflict of interest statement: A. K. Chan receives research support for unrelated research from Orthofix. P. V. Mummaneni has been a consultant for DePuy Spine, Globus, and Stryker; owns stock in Spinicity/ISD; clinical/research support for this study from NREF; receives royalties from DePuy Spine, Thieme, and Springer; and has received honoraria from AOSpine and Spineart. S. D. Glassman is an employee of Norton Healthcare and holds a patent with, has been a consultant for, and receives royalties from Medtronic. K. T. Foley has been a consultant for, receives royalties from, holds a patent with, and owns stock in Medtronic; owns stock in and holds a patent with NuVasive; owns stock in and is a member of the board of directors for Discgenics and TrueVision; and owns stock in Spine Wave. E. A. Potts has been a consultant for Medtronic. D. Coric has been a consultant for Spine Wave, Stryker, Medtronic, Globus Medical, and Premia Spine and owns stock in Spine Wave and Premia Spine. J. J. Knightly has a personal relationship with National Physicians Alliance board of directors. P. Park has been a consultant for Globus, Medtronic, NuVasive, and Zimmer-Biomet and receives royalties from Globus. K.-M. Fu has been a consultant for SI-BONE. J. R. Slotkin has been a consultant for Stryker and Medtronic. E. F. Bisson owns stock in NView; receives fellowship funding from Globus; and receives funding from PCORI.